GB0410379D0 - Treatment of cancer - Google Patents

Treatment of cancer

Info

Publication number
GB0410379D0
GB0410379D0 GB0410379A GB0410379A GB0410379D0 GB 0410379 D0 GB0410379 D0 GB 0410379D0 GB 0410379 A GB0410379 A GB 0410379A GB 0410379 A GB0410379 A GB 0410379A GB 0410379 D0 GB0410379 D0 GB 0410379D0
Authority
GB
United Kingdom
Prior art keywords
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0410379A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Leicester
Original Assignee
University of Leicester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Leicester filed Critical University of Leicester
Priority to GB0410379A priority Critical patent/GB0410379D0/en
Publication of GB0410379D0 publication Critical patent/GB0410379D0/en
Priority to PCT/GB2005/001765 priority patent/WO2005107782A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0410379A 2004-05-11 2004-05-11 Treatment of cancer Ceased GB0410379D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0410379A GB0410379D0 (en) 2004-05-11 2004-05-11 Treatment of cancer
PCT/GB2005/001765 WO2005107782A2 (en) 2004-05-11 2005-05-10 Use of a modulator of gene expression in the treatment of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0410379A GB0410379D0 (en) 2004-05-11 2004-05-11 Treatment of cancer

Publications (1)

Publication Number Publication Date
GB0410379D0 true GB0410379D0 (en) 2004-06-16

Family

ID=32526744

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0410379A Ceased GB0410379D0 (en) 2004-05-11 2004-05-11 Treatment of cancer

Country Status (2)

Country Link
GB (1) GB0410379D0 (en)
WO (1) WO2005107782A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170123607A (en) 2014-12-11 2017-11-08 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Cell Necrosis Inhibitors and Related Methods
CN111808958A (en) * 2020-07-13 2020-10-23 青岛市市立医院 PCR reagent for detecting apoptosis signal path and application thereof
WO2024049971A2 (en) * 2022-09-02 2024-03-07 Baylor College Of Medicine Modulation of b-cell translocation gene 1 (btg1) for use in adoptive cell therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650316A (en) * 1994-06-06 1997-07-22 Research Development Foundation Uses of triplex forming oligonucleotides for the treatment of human diseases
AU2003256453A1 (en) * 2002-07-03 2004-01-23 The Trustees Of Columbia University In The City Of New York Methods for identifying modulators of mda-7 mediated apoptosis

Also Published As

Publication number Publication date
WO2005107782A2 (en) 2005-11-17
WO2005107782A3 (en) 2006-02-02

Similar Documents

Publication Publication Date Title
ZA200800907B (en) Treatment of cancer
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
HK1204476A1 (en) Compounds and methods for treatment of cancer
IL188430A0 (en) Treatment of tumors
IL197315A0 (en) Treatment of cancer
IL179129A0 (en) Kit for treatment of cancer
EP1838330A4 (en) Treatment of solid cancers
HK1117780A1 (en) Compounds and methods for the treatment of cancer
EP1830847A4 (en) Treatment for cancer
GB0428187D0 (en) Cancer treatment
GB0413346D0 (en) Treating cancer
IL187792A0 (en) 4-anilino-3-quinolinecarbonitriles for the treatment of cancer
GB0426196D0 (en) Methods of treatment
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0329416D0 (en) Treatment of cancer
GB0520067D0 (en) Treatment of cancer
GB0410379D0 (en) Treatment of cancer
IL180709A0 (en) Treatment of tumours
GB0423273D0 (en) Treatment of cancer
GB0404675D0 (en) Cancer treatment
IL180460A0 (en) Treatment of cancer
GB0421734D0 (en) Treatment of cancer
ZA200700845B (en) Treatment of cancer
GB0422225D0 (en) Treatment of cancer
GB0420845D0 (en) Treatment of cancer

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)